Stock listing

Arbutus Biopharma Corporation

Selected listing: I9DN · MUN · EUR · DE

Arbutus Biopharma Corporation (Munich:I9DN), Health Technology. Latest release Oct 1, 2026: Arbutus Announces Final Results of Its US$230 Million Modified…

I9DN:MUNEURDEUpdated October 2, 2026
Arbutus Biopharma Corporation logo
Ticker
Munich:I9DN
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Munich
Currency
EUR

About Arbutus Biopharma Corporation

The company focuses on developing innovative therapies for the treatment of viral infections, particularly hepatitis B. Arbutus is committed to advancing its research and development efforts to address unmet medical needs in this area.

Latest news from Arbutus Biopharma Corporation

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

October 1, 2026

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

September 30, 2026

Arbutus Biopharma : Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

August 24, 2026

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

August 24, 2026

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer

August 21, 2026

All Arbutus Biopharma Corporation news →

Events

Replays

  • Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call

    Wed, Nov 06, 2024 · 08:45 AM ET

    Watch

  • Arbutus Biopharma Corporation (ABUS) Q2 2024 Earnings Call

    Thu, Aug 01, 2024 · 08:45 AM ET

    Watch

  • Arbutus Biopharma Corporation (ABUS) Q1 2024 Earnings Call

    Thu, May 02, 2024 · 08:45 AM ET

    Watch

Research Arbutus Biopharma Corporation

Arbutus Biopharma Corporation company profile

View the public company page for Arbutus Biopharma Corporation on 6ix.

Arbutus Biopharma Corporation news

Read company news and market updates connected to Arbutus Biopharma Corporation.

Arbutus Biopharma Corporation investor events

Find investor webinars, events, and replay context for Arbutus Biopharma Corporation.

Alternate listings

ABUS:NASDAQ

US · USD

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

A14XMD:LSX

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

A14XMD:LS

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

ABUS:BOATS

US · USD

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

I9DN:GETTEX

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

0SGC:LSE

GB · USD

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

I9DN:SWB

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

I9DN:DUS

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

I9DN:FWB

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.

I9DN:TRADEGATE

DE · EUR

Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is I9DN:MUN.